This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Jürgen Hess - Innovator in Tuberculosis Vaccine Development.
Introduction
Jürgen Hess is a notable inventor based in Baiersdorf, Germany. He has made significant contributions to the field of medical research, particularly in the development of vaccines. His work focuses on improving the efficacy of vaccines against tuberculosis, a disease that poses a significant global health challenge.
Latest Patents
Jürgen Hess holds a patent for a tuberculosis vaccine with improved efficacy. The present invention relates to novel recombinant vaccines that provide protective immunity against tuberculosis. Furthermore, it refers to novel recombinant nucleic acid molecules, vectors containing these nucleic acid molecules, cells transformed with these nucleic acid molecules, and polypeptides encoded by these nucleic acid molecules. He has 1 patent in this area.
Career Highlights
Hess is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a prestigious research organization in Germany. His work at this institution has allowed him to engage in cutting-edge research and contribute to advancements in vaccine technology.
Collaborations
Throughout his career, Jürgen Hess has collaborated with esteemed colleagues, including Leander Grode and Stefan H. E. Kaufmann. These collaborations have further enriched his research and have been instrumental in the development of innovative solutions to combat tuberculosis.
Conclusion
Jürgen Hess is a dedicated inventor whose work in tuberculosis vaccine development is making a significant impact in the field of medicine. His innovative approach and collaboration with other experts highlight the importance of teamwork in advancing healthcare solutions.